Roza Vaksengiser
Family · Brooklyn, NYNPI 1881993400
Payments from drug & device makers
Across 59 payments — averaging $42.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$527
- Johnson & Johnson$326
- Beigene USA, Inc.$300
- Pharmacosmos Therapeutics Inc.$200
- Coherus Oncology, Inc.$148
- E.r. Squibb & Sons, L.L.C.$145
- plus $848 from 15 others
What the payments were for
- Food & beverage$2,12385%
- Education$37015%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 19 | $527 |
| Johnson & Johnson | 6 | $326 |
| Beigene USA, Inc. | 2 | $300 |
| Pharmacosmos Therapeutics Inc. | 5 | $200 |
| Coherus Oncology, Inc. | 2 | $148 |
| E.r. Squibb & Sons, L.L.C. | 3 | $145 |
| AbbVie | 2 | $129 |
| Sobi, Inc | 1 | $125 |
| AstraZeneca | 1 | $121 |
| Seagen Inc. | 1 | $100 |
| Novartis | 4 | $68 |
| Bristol Myers Squibb | 2 | $54 |
| Merck | 2 | $53 |
| Astellas Pharma US Inc | 2 | $46 |
| Acrotech Biopharma Inc. | 1 | $28 |
| Gilead | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Celltrion USA Inc. | 1 | $20 |
| Geron Corporation | 1 | $19 |
| G1 Therapeutics, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,493 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 25 | $610 |
| ValacyclovirValacyclovir Hcl | 16 | $336 |
| LoperamideLoperamide Hcl | 18 | $326 |
| Dexamethasone | 14 | $65 |
| Mupirocin | 12 | $50 |
Paid to pharmacies, not to this prescriber.
Other family in Brooklyn
- Seida VelijaBrooklyn$62K
- Ofiong OkonBrooklyn$44K
- Irina FainbergBrooklyn$23K
- Susan WeissBrooklyn$22K
- Razan AlawadhiBrooklyn$21K
- Christina LaoBrooklyn$20K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.